Seelos Therapeutics (SEELQ) Stock Statistics & Valuation Metrics

Seelos Therapeutics has a market cap or net worth of $112.00. The enterprise value is $11.36M.

Seelos Therapeutics has 1,124,121 shares outstanding. The number of shares has decreased by -2.65% in one year.

Seelos Therapeutics’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Seelos Therapeutics is ―. Seelos Therapeutics’s PEG ratio is ―.

In the last 12 months, Seelos Therapeutics had revenue of ― and earned -37.88M in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Seelos Therapeutics pays an annual dividend of ―, resulting in a dividend yield of ―

Seelos Therapeutics upcoming earnings date is Apr 25, 2025, TBA (Confirmed).

Seelos Therapeutics as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Seelos Therapeutics has paid ― in taxes.

Seelos Therapeutics EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Seelos Therapeutics has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Seelos Therapeutics is ―, which is 11.43% higher than the current price. The consensus rating is ―